Dr. Tripsas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
200 Ucla Medical Plz Ste 365b
Los Angeles, CA 90095Phone+1 310-825-7921Fax+1 310-794-6553
Education & Training
Yale-New Haven Medical CenterResidency, Internal Medicine, 2018 - 2021
University of Arkansas For Medical Sciences College of MedicineClass of 2018
Certifications & Licensure
CA State Medical License 2021 - 2025
CT State Medical License 2018 - 2021- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Pulmonary Disease
Publications & Presentations
PubMed
- 16 citationsProspective, Multicenter Clinical Trial of Everolimus as Primary Therapy in Waldenstrom Macroglobulinemia (WMCTG 09-214)Steven P. Treon, Kirsten Meid, Christina K. Tripsas, Leonard T. Heffner, Herbert Eradat
Clinical Cancer Research. 2017-05-15 - 676 citationsIbrutinib in Previously Treated Waldenström’s MacroglobulinemiaSteven P. Treon, Christina K. Tripsas, Kirsten Meid, Diane Warren, Gaurav Varma
The New England Journal of Medicine. 2015-04-08 - 139 citationsCarfilzomib, rituximab, and dexamethasone (CaRD) treatment offers a neuropathy-sparing approach for treating Waldenström's macroglobulinemia.Steven P. Treon, Christina K. Tripsas, Kirsten Meid, Sandra Kanan, Patricia Sheehy
Blood. 2014-07-24
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
